Study
Lavender Oil Shows Promise for Managing Anxiety in Adults
A study found that silexan, a lavender oil preparation, effectively reduces anxiety symptoms with fewer side effects.
Summary
In plain language
Research has revealed that a lavender oil preparation called silexan may be a promising option for adults dealing with anxiety, including generalized anxiety disorder (GAD). The study found that silexan was just as effective as some traditional anti-anxiety medications in reducing anxiety symptoms, with a lower risk of side effects. This could be significant for seniors searching for treatments that don't carry the dependency risks associated with some medications. As always, it's wise to discuss any new treatment options with your healthcare provider.
Details
Use the full description to understand the study design, methods, and the limits of the findings.
This study conducted a comprehensive review of various treatments for anxiety disorders, focusing on their effectiveness and side effects. Researchers analyzed data from 100 trials involving over 28,000 participants. They found that silexan, a lavender oil preparation, was particularly effective at reducing anxiety symptoms without the side effects common in other medications.
The study used data from 1980 to 2020, comparing different anxiety treatments, including traditional medications and silexan.
Silexan was as effective as some conventional drugs but had fewer side effects, making it a potentially safer option.
The study emphasized the importance of finding treatments that patients find acceptable and sustainable.
If you're considering treatment options for anxiety, discuss silexan with your healthcare provider to see if it might be suitable for you.
Full Study
Open the original publication for the complete methods, outcomes, and source material.
Lavender Oil Shows Promise for Managing Anxiety in Adults
Published January 2026
Opens at the publisher · external site · may require institutional access
Research Quality Score
Scored September 27, 2026 using rubric mq-1.8_2026-07-06.
Assessment
The study scored well in study design and transparency due to its systematic approach and adherence to PRISMA-NMA guidelines. Bias control was moderate, as some included studies had high risk of bias. Statistical integrity was strong, with appropriate methods and handling of heterogeneity. However, conflicts of interest were present due to industry funding, and the study's relevance to the target population was low as it did not focus on older adults. Journal quality could not be assessed.
Category Breakdown
| Category | Score | Rating |
|---|---|---|
| Study design | 10.0/10 | |
| Bias control | 6.7/10 | |
| Statistical methods | 10.0/10 | |
| Reporting completeness | 10.0/10 | |
| Conflicts & funding | 5.0/10 | |
| Replication | 0.0/10 | |
| Relevance to chosen population | 0.0/10 | |
| Journal Reliability | 5.0/10 |
Additional Notes
This meta-analysis evaluates the efficacy and acceptability of various anxiolytic drugs, including silexan, for treating anxiety disorders in adults. It uses a network meta-analysis approach to compare treatments based on HAM-A scores and discontinuation rates.
Assessed on the study's full text across 8 quality dimensions; conflict-of-interest disclosures were reviewed.
Take the next step
Build a personalized plan using research-backed studies, conditions, and treatments.